Esther Rajavelu's Insider Trades & SAST Disclosures
Esther Rajavelu's most recent trade in Spero Therapeutics Inc was a trade of 185,000 Common Stock done . Disclosure was reported to the exchange on May 2, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Esther Rajavelu.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Spero Therapeutics Inc | Esther Rajavelu | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 185,000 | 909,720 (4%) | 0% | 0 | Common Stock | |
| Spero Therapeutics Inc | Esther Rajavelu | CFO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 266,139 | 645,409 (3%) | 1% | 0 | Common Stock | |
| Spero Therapeutics Inc | Esther Rajavelu | CFO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 100,000 | 745,409 (3%) | 0% | 0 | Common Stock | |
| Spero Therapeutics Inc | Esther Rajavelu | CFO & CBO | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 03 Feb 2025 | 20,689 | 724,720 (3%) | 0% | 0.8 | 16,137 | Common Stock |
| Spero Therapeutics Inc | Esther Rajavelu | CFO & CBO | Sale of securities on an exchange or to another person at price $ 1.31 per share. | 07 Nov 2024 | 23,351 | 396,515 (2%) | 0% | 1.3 | 30,590 | Common Stock |
| Spero Therapeutics Inc | Esther Rajavelu | CFO & CBO | Sale of securities on an exchange or to another person at price $ 1.30 per share. | 07 Nov 2024 | 17,245 | 379,270 (1%) | 0% | 1.3 | 22,419 | Common Stock |
| Spero Therapeutics Inc | Rajavelu Esther | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 119,866 | 419,866 (2%) | 0% | 0 | Common Stock | |
| Fulcrum Therapeutics Inc | Esther Rajavelu | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 160,000 | 160,000 | - | - | Stock Option (right to buy) | |
| Fulcrum Therapeutics Inc | Esther Rajavelu | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 200,000 | 200,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges